OPIANT PHARMACEUTICALS, INC. - 683750103

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q4 2022 · Q3 2022
Value (USD)
Total reported value ($000)
$21.92M
QoQ value delta ($000)
+$12.18M (+125.03%)
Implied price effect (QoQ)
+88.61%
Shares
Total shares
1,081,364
QoQ shares delta
+175,014 (+19.31%)
Total shares held by funds (by quarter)

Top holders (Q4 2022)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
MORGAN STANLEY 4,008 197,652 0.0%
VANGUARD GROUP INC 3,868 190,773 0.0%
RENAISSANCE TECHNOLOGIES LLC 2,969 146,415 0.0%
WELLS FARGO & COMPANY/MN 2,774 136,814 0.0%
DIMENSIONAL FUND ADVISORS LP 2,032 100,209 0.0%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 1,255 61,912 0.01%
GEODE CAPITAL MANAGEMENT, LLC 985 48,591 0.0%
Schonfeld Strategic Advisors LLC 857 42,300 0.01%
NORTHERN TRUST CORP 784 38,679 0.0%
GABELLI FUNDS LLC 752 37,119 0.01%
TWO SIGMA ADVISERS, LP 377 18,600 0.0%
STATE STREET CORP 326 16,085 0.0%
CITADEL ADVISORS LLC 287 14,169 0.0%
Mariner, LLC 214 10,550 0.0%
GAMCO INVESTORS, INC. ET AL 202 10,000 0.0%
ADVISOR GROUP HOLDINGS, INC. 111 5,500 0.0%
UBS Group AG 56 2,802 0.0%
ROYAL BANK OF CANADA 24 1,200 0.0%
BANK OF AMERICA CORP /DE/ 21 1,070 0.0%
Tower Research Capital LLC (TRC) 15 744 0.0%
Federation des caisses Desjardins du Quebec 3 180 0.0%